# Continued Access to the Recell® Device for Treatment of Acute Burn Injuries

> **NCT03333941** · — · COMPLETED · sponsor: **Avita Medical** · enrollment: 76 (actual)

## Conditions studied

- Burns

## Interventions

- **DEVICE:** ReCell® Autologous Cell Harvesting Device

## Key facts

- **NCT ID:** NCT03333941
- **Lead sponsor:** Avita Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-26
- **Primary completion:** 2018-12-19
- **Final completion:** 2019-05-08
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2024-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03333941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03333941, "Continued Access to the Recell® Device for Treatment of Acute Burn Injuries". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03333941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*